
Sign up to save your podcasts
Or


The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
SARS-CoV-2 Vaccines
By JAMA Network4.3
106106 ratings
The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Article(s):
SARS-CoV-2 Vaccines

506 Listeners

163 Listeners

38 Listeners

21 Listeners

15 Listeners

11 Listeners

8 Listeners

17 Listeners

19 Listeners

5 Listeners

6 Listeners

31 Listeners

10 Listeners

90 Listeners

14 Listeners

5 Listeners

5 Listeners

19 Listeners

2 Listeners